Journal
AGING-US
Volume 12, Issue 2, Pages 1332-1365Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/aging.102686
Keywords
esophageal squamous cell carcinoma; DNA methylation; next-generation sequencing; histone modification; survival analysis
Categories
Funding
- National Cohort of Esophageal Cancer of China [2016YFC09014000]
- National Science Foundation of China [81772532, 81472613]
- Natural Science Foundation of China-Guangdong Joint Fund [U1601229]
Ask authors/readers for more resources
Aberrant DNA methylation leads to abnormal gene expression, making it a significant regulator in the progression of cancer and leading to the requirement for integration of gene expression with DNA methylation. Here, we identified 120 genes demonstrating an inverse correlation between DNA methylation and mRNA expression in esophageal squamous cell carcinoma (ESCC). Sixteen key genes, such as SIX4, CRABP2, and EHD3, were obtained by filtering 10 datasets and verified in paired ESCC samples by qRT-PCR. 5-Aza-dC as a DNA methyltransferase (DNMT) inhibitor could recover their expression and inhibit clonal growth of cancer cells in seven ESCC cell lines. Furthermore, 11 of the 16 genes were correlated with OS (overall survival) and DFS (disease-free survival) in 125 ESCC patients. ChIP-Seq data and WGBS data showed that DNA methylation and H3K27ac histone modification of these key genes displayed inverse trends, suggesting that there was collaboration between DNA methylation and histone modification in ESCC. Our findings illustrate that the integrated multi-omics data (transcriptome and epigenomics) can accurately obtain potential prognostic biomarkers, which may provide important insight for the effective treatment of cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available